Edwards Lifesciences (EW) Non Operating Income (2009 - 2026)

Edwards Lifesciences' Non Operating Income history runs 18 years deep, the most recent figure standing at $71.5 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 2650.0% year-over-year to $71.5 million; the TTM figure through Mar 2026 stood at $50.8 million (down 22.8% YoY), while the FY2025 annual figure was $8.7 million, down 87.37% from the prior year.
• Non Operating Income was $71.5 million for Q1 2026 at Edwards Lifesciences, up from -$60.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $71.5 million in Q1 2026 to a low of -$60.7 million in Q4 2025.
• Historically, Non Operating Income has averaged $9.3 million across 5 years, with a median of $3.6 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Non Operating Income slumped 282.28% in 2025, then surged 2650.0% in 2026.
• A 5-year view of Non Operating Income shows it stood at $5.8 million in 2022, then plunged by 37.93% to $3.6 million in 2023, then jumped by 825.0% to $33.3 million in 2024, then plunged by 282.28% to -$60.7 million in 2025, then soared by 217.79% to $71.5 million in 2026.
• The last three Non Operating Income figures came in at $71.5 million (Q1 2026), -$60.7 million (Q4 2025), and $41.3 million (Q3 2025), per Business Quant data.